Expression data from Human bone mesenchymal stem cells

Analysis of Human bone mesenchymal stem cells treated separately with DMSO vehicle, 100 nM perfluorooctanesulfonat(PFOS), 100 nM perfluorooctanoic acid(PFOA), 100 nM perfluorohexanesulphonate(PFHxS) or100 nM Chlorinated polyfluoroalkyl ether sulfonate(F-53B) for 7 days. Results provide insight into the molecular mechanisms by which PFASs interfere with osteogenic differentiation potential in HBMSCs. The expression profile of HBMSCs grown for 7 days in basic medium supplemented with DMSO vehicle, 100 nM PFOS, 100 nM PFOA, 100 nM PFHxS or100 nM F-53B, with the three biological replicates, were examined using microarray analysis.